![]()
|
Report Date : |
13.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MALLARD PHARMACEUTICALS (PRIVATE) LTD |
|
|
|
|
Registered Office : |
Zia Lodge, Jinnah Town District, Jail Road, Multan |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
2005 |
|
|
|
|
Com. Reg. No.: |
0049649 |
|
|
|
|
Legal Form : |
Private Limited
Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical Products for human and
Animal, Biological Medicine |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
MALLARD PHARMACEUTICALS (PRIVATE) LTD
Registered
Address
|
|
Zia Lodge, Jinnah Town District, Jail Road, Multan, Pakistan |
|
Tel |
92 (61) 4543672, 4542731 |
|
Fax |
92 (61) 4510512 |
|
Website |
|
Nature of Business |
Manufacture & Marketing of
Pharmaceutical Products for human & Animal, Biological Medicine |
|
Year Established |
2005 |
|
Registration # |
0049649 |
23 - K.M., Lahore Road,
Multan, Pakistan
Mahboob Sheikh &
Company
(Chartered Accountants)
Near HBL Building, Near
Auto Plaza, Dera Adda Chowk, L.M.Q. Road, Multan, Pakistan
Subject Company was
established as a Private Limited Company in 2005
|
Authorized Capital |
Rs. 10,000,000/- |
|
Issued & Paid
up Capital |
Rs. 10,000,000/- |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Zaheer-Ud-Din Babar Mr. Mohaio-Ud-Din Aurangzeb Alamgir Mr. Jalal-Ud-Din Akbar Mr. Shahabuddin Mr. Jahanzaib Humayoun |
Pakistani Pakistani Pakistani Pakistani Pakistani |
Zia Lodge, Jinnah Town District, Jail Road,
Multan Zia Lodge, Jinnah Town District, Jail Road,
Multan Zia Lodge, Jinnah Town District, Jail Road,
Multan Zia Lodge, Jinnah Town District, Jail Road,
Multan Zia Lodge, Jinnah Town District, Jail Road,
Multan |
Business Business Business Business Business |
Chief Executive Director Director Director Director |
Names
Mr. Zaheer-Ud-Din
Babar
Mr. Mohaio-Ud-Din
Aurangzeb Alamgir
Mr. Jalal-Ud-Din
Akbar
Mr. Shahabuddin
Mr. Jahanzaib
Humayoun
A. Subsidiary
None
B. Associated Companies
(1) Thames
Pharmaceuticals, Pakistan.
Manufacture &
Marketing of Pharmaceutical Products for human & Animal, Biological
Medicine
65
MURLI KRISHNA (PVT) LIMITED, INDIA.
ZHUHAI UNITED LABORATORIES CO., LTD, CHINA.
The capacity and
production of the company’s plant is indeterminable as it involves varying
processes of manufacture.
|
Year |
In Pak Rupees |
|
2007 - 2008 |
Not
ascertained as the subject recently started
its commercial production |
Company are in the process of making distributors in all major cities of
Pakistan
(1) National Bank of
Pakistan, Pakistan.
(Mortgage obtained PKR 10,000,000/-)
(2) Faysal Bank Limited,
Pakistan.
(3) Standard
Chartered Bank, Pakistan.
|
Currency |
Unit |
Pakistani
Rupee |
|
US Dollar |
1 |
Rs. 67.70 |
|
UK Pound |
1 |
Rs. 131.45 |
|
Euro |
1 |
Rs. 104.20 |
Subject Company was established in 2005 and is engaged in manufacture
& marketing of Pharmaceutical Products for human & Animal, Biological Medicine. Overall reputation is
normal. Trade relations are reported as fair. The Company can be considered for
normal business dealings at usual trade terms & conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)